Cannabis and psychosis: what is the link?
Growing evidence supports the hypothesis that cannabis consumption is a risk factor for the development of psychotic symptoms. Nonetheless, controversy remains about the causal nature of the association. This review takes the debate further through a critical appraisal of the evidence. An electronic search was performed, allowing to identify 622 studies published until June 1st 2005. Longitudinal studies and literature reviews were selected if they addressed specifically the issues of the cannabis/psychosis relationship or possible mechanisms involved. Ten epidemiological studies were relevant: three supported a causal relationship between cannabis use and diagnosed psychosis; five suggested that chronic cannabis intake increases the frequency of psychotic symptoms, but not of diagnosed psychosis; and two showed no causal relationship. Potential neurobiological mechanisms were also identified, involving dopamine, endocannabinoids, and brain growth factors. Although there is evidence that cannabis use increases the risk of developing psychotic symptoms, the causal nature of this association remains unclear. Contributing factors include heavy consumption, length and early age of exposure, and psychotic vulnerability. This conclusion should be mitigated by uncertainty arising from cannabis use assessment, psychosis measurement, reverse causality and control of residual confounding.
Ben Amar
Mohamed
M
Faculties of Continuing Education and Graduate Studies, University of Montreal, Quebec, Canada. mohamed.ben.amar@umontreal.ca
Potvin
Stéphane
S
D000367:Age Factors; D002188:Cannabis / Q000737:chemistry*; D015986:Confounding Factors, Epidemiologic; D016021:Epidemiologic Studies; D006801:Humans; D002189:Marijuana Abuse / Q000453:epidemiology; D008385:Marijuana Smoking / Q000009:adverse effects*; D011618:Psychotic Disorders / Q000453:epidemiology / Q000209:etiology*; D012307:Risk Factors; D013997:Time Factors